Description
Product Characteristics:
Aliases: 90 kDa ribosomal protein S6 kinase 3 antibody, CLS antibody, HU 3 antibody, HU2 antibody, HU3 antibody, Insulin stimulated protein kinase 1 antibody, Insulin-stimulated protein kinase 1 antibody, ISPK-1 antibody, ISPK1 antibody, KS6A3_HUMAN antibody, MAP kinase activated protein kinase 1b antibody, MAP kinase-activated protein kinase 1b antibody, MAPK activated protein kinase 1b antibody, MAPK-activated protein kinase 1b antibody, MAPKAP kinase 1b antibody, MAPKAPK 1b antibody, MAPKAPK-1b antibody, MAPKAPK1B antibody, Mental retardation, X linked 19 antibody, MRX19 antibody, OTTHUMP00000023036 antibody, p90 RSK2 antibody, p90 RSK3 antibody, p90-RSK 3 antibody, p90RSK3 antibody, pp90RSK2 antibody, Ribosomal protein S6 kinase 90 kDa polypeptide 3 antibody, Ribosomal protein S6 kinase alpha 3 antibody, Ribosomal protein S6 kinase alpha-3 antibody, Ribosomal protein s6 kinase ii alpha 2 antibody, Ribosomal S6 kinase 2 antibody, Rps6ka3 antibody, RSK antibody, RSK-2 antibody, RSK2 antibody, S6 kinase 2 antibody, S6K alpha3 antibody, S6K-alpha-3 antibody
Target Information: This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). [provided by RefSeq, Jul 2008]